Hopman Mark (CIK 2048497) reported 24 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell BBNX (35,994 shares), Sell BBNX (30,779 shares), Sell BBNX (775 shares), Sell BBNX (36,870 shares), Sell BBNX (5,327 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 35,994 | $664,550 |
| 2026-09-17 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 30,779 | $619,640 |
| 2026-09-15 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 775 | $12,028 |
| 2026-09-10 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 36,870 | $680,723 |
| 2026-09-03 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 5,327 | $101,815 |
| 2026-06-25 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 1,258 | $18,883 |
| 2026-06-05 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 275 | $3,385 |
| 2026-06-03 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 5,329 | $67,199 |
| 2026-03-16 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 856 | $25,115 |
| 2026-03-16 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 2,061 | $63,190 |
| 2026-03-05 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 353 | $4,084 |
| 2026-03-03 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 834 | $10,308 |
| 2026-03-03 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Buy | 109,105 | $0 |
| 2025-09-08 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Buy | 656 | $3,346 |
| 2025-09-08 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Buy | 4,093 | $20,874 |
| 2025-09-08 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 6,818 | $136,155 |
| 2025-09-08 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Buy | 11,411 | $58,196 |
| 2025-09-08 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 11,411 | $234,610 |
| 2025-09-04 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 848 | $15,993 |
| 2025-08-20 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Buy | 16,158 | $82,406 |
| 2025-08-20 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 16,158 | $268,384 |
| 2025-06-04 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 238 | $4,053 |
| 2025-06-04 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 551 | $10,001 |
| 2025-06-04 | Beta Bionics, Inc. (BBNX) | Chief Commercial Officer | Sell | 79 | $1,477 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18